Canadian Urological Association guideline on androgen deprivation therapy: Adverse events and management strategies

Authors

  • Andrea Kokorovic
  • Alan I. So
  • Hosam Serag
  • Christopher French
  • Robert J. Hamilton
  • Jason P. Izard
  • Jasmir G. Nayak
  • Fréderic Pouliot
  • Fred Saad
  • Bobby Shayegan
  • Armen Aprikian
  • Ricardo A. Rendon

DOI:

https://doi.org/10.5489/cuaj.7355

Keywords:

ADT, prostate cancer, CV risk, bone health

Abstract

NA

Downloads

Download data is not yet available.

Published

2021-04-21

How to Cite

Kokorovic, A. ., So, A. I. ., Serag, H. ., French, C. ., Hamilton, R. J. ., Izard, J. P. ., Nayak, J. G. ., Pouliot, F. ., Saad, F. ., Shayegan, B. ., Aprikian, A. ., & Rendon, R. A. . (2021). Canadian Urological Association guideline on androgen deprivation therapy: Adverse events and management strategies . Canadian Urological Association Journal, 15(6), E307–22. https://doi.org/10.5489/cuaj.7355

Issue

Section

CUA Guideline